Clinical Trial Update: An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study [Phase 4]

View source ↗

Summary

An extension study to provide continued bevacizumab therapy for participants who were previously enrolled in a Roche/Genentech study; Phase 4 completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• bevaczizumab (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neoplasms | Phase 4 | Status: COMPLETED | Results posted: 2020-11-05